184 related articles for article (PubMed ID: 29778534)
1. Fibroblast growth factor 19 protects the heart from oxidative stress-induced diabetic cardiomyopathy via activation of AMPK/Nrf2/HO-1 pathway.
Li X; Wu D; Tian Y
Biochem Biophys Res Commun; 2018 Jul; 502(1):62-68. PubMed ID: 29778534
[TBL] [Abstract][Full Text] [Related]
2. Fortunellin protects against high fructose-induced diabetic heart injury in mice by suppressing inflammation and oxidative stress via AMPK/Nrf-2 pathway regulation.
Zhao C; Zhang Y; Liu H; Li P; Zhang H; Cheng G
Biochem Biophys Res Commun; 2017 Aug; 490(2):552-559. PubMed ID: 28624452
[TBL] [Abstract][Full Text] [Related]
3. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats.
Kosuru R; Kandula V; Rai U; Prakash S; Xia Z; Singh S
Cardiovasc Drugs Ther; 2018 Apr; 32(2):147-163. PubMed ID: 29556862
[TBL] [Abstract][Full Text] [Related]
5. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
8. Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy.
Li H; Shi Y; Wang X; Li P; Zhang S; Wu T; Yan Y; Zhan Y; Ren Y; Rong X; Xia T; Chu M; Wu R
Chem Biol Interact; 2019 Sep; 310():108754. PubMed ID: 31323227
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1.
Li H; Yao W; Irwin MG; Wang T; Wang S; Zhang L; Xia Z
Free Radic Biol Med; 2015 Jul; 84():311-321. PubMed ID: 25795513
[TBL] [Abstract][Full Text] [Related]
10. Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice.
Wu H; Liu G; He Y; Da J; Xie B
Eur J Pharmacol; 2019 Sep; 858():172393. PubMed ID: 31085240
[TBL] [Abstract][Full Text] [Related]
11. Mulberry granules protect against diabetic cardiomyopathy through the AMPK/Nrf2 pathway.
Liu Y; Zhao YB; Wang SW; Zhou Y; Tang ZS; Li F
Int J Mol Med; 2017 Sep; 40(3):913-921. PubMed ID: 28677741
[TBL] [Abstract][Full Text] [Related]
12. Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy.
Ge ZD; Lian Q; Mao X; Xia Z
Int Heart J; 2019 May; 60(3):512-520. PubMed ID: 30971629
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.
Li C; Zhang J; Xue M; Li X; Han F; Liu X; Xu L; Lu Y; Cheng Y; Li T; Yu X; Sun B; Chen L
Cardiovasc Diabetol; 2019 Feb; 18(1):15. PubMed ID: 30710997
[TBL] [Abstract][Full Text] [Related]
14. Beneficial Role of Some Natural Products to Attenuate the Diabetic Cardiomyopathy Through Nrf2 Pathway in Cell Culture and Animal Models.
Sathibabu Uddandrao VV; Brahmanaidu P; Nivedha PR; Vadivukkarasi S; Saravanan G
Cardiovasc Toxicol; 2018 Jun; 18(3):199-205. PubMed ID: 29080123
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
16. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
17. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
[TBL] [Abstract][Full Text] [Related]
18. Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling.
Zhang H; Liu YY; Jiang Q; Li KR; Zhao YX; Cao C; Yao J
Free Radic Biol Med; 2014 Apr; 69():219-28. PubMed ID: 24486344
[TBL] [Abstract][Full Text] [Related]
19. Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress.
Li G; Yang L; Feng L; Yang J; Li Y; An J; Li D; Xu Y; Gao Y; Li J; Liu J; Yang L; Qi Z
Mol Nutr Food Res; 2020 Sep; 64(18):e2000231. PubMed ID: 32729956
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
